| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 19 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $21.01M | - | |
| CEO | 1.74M | $11.07M | -41,666 | |
| Other | 409.9K | $2.61M | - | |
| CFO | 409.1K | $2.60M | - | |
| Other | 339.5K | $2.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | Grammer Elizabeth A58 | See Remarks | Sell | 1,242 | $1.95 | $2,420.72 | -0.2% | +58.9% | +133.0% | |
| Nov 22, 2022 | Rodriguez Susan45 | Chief Commercial Officer | Sell | 3,456 | $1.95 | $6,735.70 | -0.4% | +58.9% | +133.0% | |
| Nov 22, 2022 | Raab Michael56 | President &CEO | Sell | 6,219 | $1.95 | $12,120.29 | -0.3% | +58.9% | +133.0% | |
| Nov 22, 2022 | Renz Justin A54 | Chief Financial Officer | Sell | 1,504 | $1.95 | $2,931.27 | -0.3% | +58.9% | +133.0% | |
| Nov 22, 2022 | Williams Laura A55 | Chief Medical Officer | Sell | 1,241 | $1.95 | $2,418.82 | -0.2% | +58.9% | +133.0% | |
| Nov 22, 2022 | Blanks Robert | See Remarks | Sell | 1,464 | $1.95 | $2,853.32 | -0.2% | +58.9% | +133.0% | |
| Nov 17, 2022 | Mott David M88 | Director | Buy | 567,000 | $1.76 | $1,000,641.60 | +94.5% | +75.6% | +151.7% | |
| Oct 5, 2022 | Blanks Robert | See Remarks | Sell | 100,000 | $1.50 | $150,000.00 | -33.8% | +77.5% | +167.5% | |
| Sep 1, 2022 | Rosenbaum David P.59 | Chief Development Officer | Sell | 3,000 | $0.92 | $2,760.30 | -3.2% | +75.5% | +391.8% | |
| Aug 31, 2022 | Rosenbaum David P.59 | Chief Development Officer | Buy | 3,000 | $0.62 | $1,856.40 | +3.4% | +84.6% | +349.4% |